Tuesday, April 28, 2020

Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets

Glenmark Pharma gets tentative USFDA nod for generic anti-diabetes tablets The approval granted by the United States Food and Drug Administration (USFDA) to Glenmark Pharmaceuticals Inc., USA, is for the strength of 10 mg/5 mg tablets, the generic version of Qtern tablets of the same strength of AstraZeneca AB, the company said in a statement.

from Moneycontrol Business News https://ift.tt/3d02wA2
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

A 'non-event Budget' for stock market: Is that good news for Nifty which fell 1,000 points in January?

As Budget 2026 approaches, analysts expect a low-impact event for equities amid muted expectations. With Nifty already down sharply in Janua...